Ravandi, Farhad
The University of Texas MD Anderson Cancer Center,
United States
2025 Rank: 6,425
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 141 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6,425 | 5,545 |
| Total Cites | 4,977 | 5,861 |
| H-index | 30 | 33 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 37 | 37 |
| Total Cites to Single Authored Papers | 25 | 26 |
| Number of Single+First Authored Papers | 119 | 119 |
| Total Cites to Single+First Authored Papers | 208 | 245 |
| Number of Single+First+Last Authored Papers | 271 | 271 |
| Total Cites to Single+First+Last Authored Papers | 965 | 1,072 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,804 | 3,002 |
| Ratio of Total Citations to Distinct Citing Papers | 1.77 | 1.95 |
| Self-Citation Percentage |
15.08%
|
|
Ravandi, Farhad
The University of Texas MD Anderson Cancer Center,
United States
2024 Rank: 5,657
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 139 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 5,657 | 4,554 |
| Total Cites | 4,920 | 5,943 |
| H-index | 28 | 32 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 36 | 36 |
| Total Cites to Single Authored Papers | 28 | 28 |
| Number of Single+First Authored Papers | 115 | 115 |
| Total Cites to Single+First Authored Papers | 224 | 269 |
| Number of Single+First+Last Authored Papers | 259 | 259 |
| Total Cites to Single+First+Last Authored Papers | 890 | 1,034 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,630 | 2,827 |
| Ratio of Total Citations to Distinct Citing Papers | 1.87 | 2.10 |
| Self-Citation Percentage |
17.21%
|
|
Ravandi, Farhad
The University of Texas MD Anderson Cancer Center,
United States
2023 Rank: 7,665
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 190 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7,665 | 6,197 |
| Total Cites | 4,130 | 5,044 |
| H-index | 25 | 28 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 36 | 36 |
| Total Cites to Single Authored Papers | 25 | 28 |
| Number of Single+First Authored Papers | 113 | 113 |
| Total Cites to Single+First Authored Papers | 251 | 290 |
| Number of Single+First+Last Authored Papers | 249 | 249 |
| Total Cites to Single+First+Last Authored Papers | 806 | 936 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,397 | 2,588 |
| Ratio of Total Citations to Distinct Citing Papers | 1.72 | 1.95 |
| Self-Citation Percentage |
18.12%
|
|
Ravandi, Farhad
University of Texas MD Anderson Cancer Center,
United States
2022 Rank: 6,081
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 179 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6,081 | 4,300 |
| Total Cites | 3,961 | 4,867 |
| H-index | 24 | 29 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 39 | 42 |
| Number of Single+First Authored Papers | 107 | 107 |
| Total Cites to Single+First Authored Papers | 270 | 339 |
| Number of Single+First+Last Authored Papers | 235 | 235 |
| Total Cites to Single+First+Last Authored Papers | 735 | 913 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,378 | 2,573 |
| Ratio of Total Citations to Distinct Citing Papers | 1.67 | 1.89 |
| Self-Citation Percentage |
18.62%
|
|
Ravandi, Farhad
University of Texas MD Anderson Cancer Center,
United States
2021 Rank: 6,748
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 179 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6,748 | 5,302 |
| Total Cites | 5,201 | 6,422 |
| H-index | 30 | 34 |
| Hm-index | 10 | 12 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 52 | 55 |
| Number of Single+First Authored Papers | 104 | 104 |
| Total Cites to Single+First Authored Papers | 419 | 524 |
| Number of Single+First+Last Authored Papers | 219 | 219 |
| Total Cites to Single+First+Last Authored Papers | 976 | 1,199 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,262 | 3,552 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.81 |
| Self-Citation Percentage |
19.01%
|
|
Ravandi, Farhad
University of Texas MD Anderson Cancer Center,
2020 Rank: 8,219
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 202 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8,219 | 6,906 |
| Total Cites | 3,526 | 4,262 |
| H-index | 26 | 30 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 35 | 36 |
| Number of Single+First Authored Papers | 102 | 102 |
| Total Cites to Single+First Authored Papers | 317 | 388 |
| Number of Single+First+Last Authored Papers | 209 | 209 |
| Total Cites to Single+First+Last Authored Papers | 622 | 745 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,222 | 2,444 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.74 |
| Self-Citation Percentage |
17.27%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.